2011 Annual Meeting

Session: Protein Engineering I - Therapeutics

Chair

Griswold, K. E., Dartmouth College

Presentations

08:30 AM

(256a) The Exploitation of S. Cerevisiae - Improved Understanding and Optimal Yields of Single-Chain Antibody Fragment (scFv) 4-4-20
Britton, Z. T., Maurer, R. W. III, Robinson, A. S.

08:50 AM

(256b) Engineering Anti-Prion Scfv for the Treatment of Prion Diseases
O'Boyle, R. J.

09:10 AM

(256c) Protease-Activated Antibodies for Diagnostics and Therapy
Schoep, T.

09:30 AM

(256d) Engineered Monospecific and Bispecific Proteins That Target Tumor Vascular Receptors As In Vivo Imaging Agents
Moore, S. J., Leung, C. L., Norton, H., Papo, N., Cochran, J. R.

10:00 AM

(256e) A Protein Therapeutic Modality Founded On Molecular Regulation
Ostermeier, M., Wright, C. M., Wright, R. C., Eshleman, J. R.

10:20 AM

(256f) Transferrin Mediated Drug Delivery to Brain
Chandra, D., Karande, P.

10:40 AM

(256g) Protegrin Has Distinct Mechanisms of Action On Prokaryotes and Eukaryotes As Defined by Unique Morphological Changes
Volzing, K. G., Kaznessis, Y.